Marker Therapeutics Inc (MRKR)

[BluMarlin1960]

Roche has been my choice also from the outset, Edith Perez and Herceptin match, hard for Glynn to give the farm away now that he has Dart and John to account too. Not to mention how hard he has worked to get to this stage, think a billion [10] would be the starting point.

Don't think that we get anywhere near Phase 111, if science holds out even as Phase 11's start believe that we will be acquired at that point or at least certainly partnered with favorable terms.

Even at this point, the science is so compelling offers are probably circulating and most likely there will be multiple suitors.

Remember that only a year ago as we [those who went through the restructuring] were worried that Tapimmune would not be able to continue as a going concern.

The company has turned around 360, if this was not on the OTC we would be $5/10 minimum already [per others at same stages of tech/trials]

Each time I read about others and their Phase 11 trials being positive in the same space it gives more validation that TPIV's science will hold out and get stronger as Polystart and TAP find their respective places in the vaccine process.

BLU